Terms: = Sarcomas AND PAX7, PAX7B, 5081, ENSG00000009709, P23759, HUP1 AND Treatment
31 results:
1. Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR.
Heinz AT; Schönstein A; Ebinger M; Fuchs J; Timmermann B; Seitz G; Vokuhl C; Münter M; Pajtler KW; Stegmaier S; von Kalle T; Kratz CP; Ljungman G; Juntti H; Klingebiel T; Koscielniak E; Sparber-Sauer M;
Pediatr Blood Cancer; 2024 Jan; 71(1):e30707. PubMed ID: 37814424
[TBL] [Abstract] [Full Text] [Related]
2. MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells.
Cassandri M; Pomella S; Rossetti A; Petragnano F; Milazzo L; Vulcano F; Camero S; Codenotti S; Cicchetti F; Maggio R; Festuccia C; Gravina GL; Fanzani A; Megiorni F; Catanoso M; Marchese C; Tombolini V; Locatelli F; Rota R; Marampon F
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639012
[TBL] [Abstract] [Full Text] [Related]
3. Changes in FXR1 expression after Chemotherapy for Rhabdomyosarcoma.
Xu MC; Ghani MO; Apple A; Chen H; Whiteside M; Borinstein SC; Correa H; Lovvorn HN
J Pediatr Surg; 2021 Jun; 56(6):1148-1156. PubMed ID: 33736876
[TBL] [Abstract] [Full Text] [Related]
4. Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020.
Parham DM; Giannikopoulos P
Pediatr Dev Pathol; 2021; 24(2):87-95. PubMed ID: 33439112
[TBL] [Abstract] [Full Text] [Related]
5. Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor.
Michal M; Rubin BP; Kazakov DV; Michalová K; Šteiner P; Grossmann P; Hájková V; Martínek P; Švajdler M; Agaimy A; Hadravský L; Kalmykova AV; Konishi E; Heidenreich F; Michal M
Virchows Arch; 2020 Aug; 477(2):219-230. PubMed ID: 32078043
[TBL] [Abstract] [Full Text] [Related]
6. Primary cutaneous alveolar rhabdomyosarcoma in an adolescent - A challenging diagnosis.
Calvão J; Cardoso JC; Ramos L; Figueiredo A
Pediatr Dermatol; 2020 Jan; 37(1):184-186. PubMed ID: 31797424
[TBL] [Abstract] [Full Text] [Related]
7. OLIG2 is a marker of the fusion protein-driven neurodevelopmental transcriptional signature in alveolar rhabdomyosarcoma.
Raghavan SS; Mooney KL; Folpe AL; Charville GW
Hum Pathol; 2019 Sep; 91():77-85. PubMed ID: 31299267
[TBL] [Abstract] [Full Text] [Related]
8. A Review of the Role of Cytogenetics in the Diagnosis of Orbital Rhabdomyosarcoma.
Cortes Barrantes P; Jakobiec FA; Dryja TP
Semin Ophthalmol; 2019; 34(4):243-251. PubMed ID: 31146616
[TBL] [Abstract] [Full Text] [Related]
9. Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Sparber-Sauer M; Stegmaier S; Vokuhl C; Seitz G; von Kalle T; Scheer M; Münter M; Bielack SS; Weclawek-Tompol J; Ladenstein R; Niggli F; Ljungman G; Fuchs J; Hettmer S; Koscielniak E; Klingebiel T;
Pediatr Blood Cancer; 2019 Jun; 66(6):e27652. PubMed ID: 30762282
[TBL] [Abstract] [Full Text] [Related]
10. Effect of MAPK Inhibition on the Differentiation of a Rhabdomyosarcoma Cell Line Combined With CRISPR/Cas9 Technology: An In Vitro Model of Human Muscle Diseases.
De Luna N; Suarez-Calvet X; Garicano M; Fernandez-Simon E; Rojas-García R; Diaz-Manera J; Querol L; Illa I; Gallardo E
J Neuropathol Exp Neurol; 2018 Oct; 77(10):964-972. PubMed ID: 30184235
[TBL] [Abstract] [Full Text] [Related]
11. The RhoE/ROCK/ARHGAP25 signaling pathway controls cell invasion by inhibition of Rac activity.
Thuault S; Comunale F; Hasna J; Fortier M; Planchon D; Elarouci N; De Reynies A; Bodin S; Blangy A; Gauthier-Rouvière C
Mol Biol Cell; 2016 Sep; 27(17):2653-61. PubMed ID: 27413008
[TBL] [Abstract] [Full Text] [Related]
12. treatment Strategy for Pediatric Paratesticular Rhabdomyosarcoma Based on Chimeric Gene Assessment.
Unno R; Mizuno K; Ito Y; Etani T; Okada A; Kawai N; Yasui T; Saitoh S; Hayashi Y
Urology; 2016 Sep; 95():187-9. PubMed ID: 27017905
[TBL] [Abstract] [Full Text] [Related]
13. Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group.
Arnold MA; Anderson JR; Gastier-Foster JM; Barr FG; Skapek SX; Hawkins DS; Raney RB; Parham DM; Teot LA; Rudzinski ER; Walterhouse DO
Pediatr Blood Cancer; 2016 Apr; 63(4):634-9. PubMed ID: 26756883
[TBL] [Abstract] [Full Text] [Related]
14. Genetic heterogeneity in rhabdomyosarcoma revealed by SNP array analysis.
Walther C; Mayrhofer M; Nilsson J; Hofvander J; Jonson T; Mandahl N; Øra I; Gisselsson D; Mertens F
Genes Chromosomes Cancer; 2016 Jan; 55(1):3-15. PubMed ID: 26482321
[TBL] [Abstract] [Full Text] [Related]
15. Human rhabdomyosarcoma cells express functional erythropoietin receptor: Potential therapeutic implications.
Poniewierska-Baran A; Suszynska M; Sun W; Abdelbaset-Ismail A; Schneider G; Barr FG; Ratajczak MZ
Int J Oncol; 2015 Nov; 47(5):1989-97. PubMed ID: 26412593
[TBL] [Abstract] [Full Text] [Related]
16. Distinct methylation profiles characterize fusion-positive and fusion-negative rhabdomyosarcoma.
Sun W; Chatterjee B; Wang Y; Stevenson HS; Edelman DC; Meltzer PS; Barr FG
Mod Pathol; 2015 Sep; 28(9):1214-24. PubMed ID: 26226845
[TBL] [Abstract] [Full Text] [Related]
17. Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells.
Beccafico S; Morozzi G; Marchetti MC; Riccardi C; Sidoni A; Donato R; Sorci G
Carcinogenesis; 2015 Sep; 36(9):1071-83. PubMed ID: 26153023
[TBL] [Abstract] [Full Text] [Related]
18. CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma.
Olanich ME; Sun W; Hewitt SM; Abdullaev Z; Pack SD; Barr FG
Clin Cancer Res; 2015 Nov; 21(21):4947-59. PubMed ID: 25810375
[TBL] [Abstract] [Full Text] [Related]
19. Rapidly progressive congenital rhabdomyosarcoma presenting with multiple cutaneous lesions: an uncommon diagnosis and a therapeutic challenge.
Rekhi B; Qureshi SS; Narula G; Gujral S; Kurkure P
Pathol Res Pract; 2014 May; 210(5):328-33. PubMed ID: 24635971
[TBL] [Abstract] [Full Text] [Related]
20. Classification of rhabdomyosarcoma and its molecular basis.
Parham DM; Barr FG
Adv Anat Pathol; 2013 Nov; 20(6):387-97. PubMed ID: 24113309
[TBL] [Abstract] [Full Text] [Related]
[Next]
